BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 3135966)

  • 1. Antibody to hepatitis D virus (delta agent) in selected Manitoba residents, 1974-1986.
    Hannan C; Sekla L; Schacter B; Stackiw W
    Clin Invest Med; 1988 Jun; 11(3):209-12. PubMed ID: 3135966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Retrospective (1970-1984) serological study of delta antigen and antibody. Observations on seroconversion and absence of delta in non-A, non-B hepatitis].
    Stroun J; Peitrequin R; Frei PC
    Schweiz Med Wochenschr; 1987 Feb; 117(9):307-14. PubMed ID: 3105053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-hepatitis B core immunoglobulin M in the serologic evaluation of hepatitis B virus infection and simultaneous infection with type B, delta agent, and non-A, non-B viruses.
    Perrillo RP; Chau KH; Overby LR; Decker RH
    Gastroenterology; 1983 Jul; 85(1):163-7. PubMed ID: 6406288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High prevalence of hepatitis delta virus infection detectable by enzyme immunoassay among apparently healthy individuals in Mongolia.
    Inoue J; Takahashi M; Nishizawa T; Narantuya L; Sakuma M; Kagawa Y; Shimosegawa T; Okamoto H
    J Med Virol; 2005 Jul; 76(3):333-40. PubMed ID: 15902700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of HIV disease on serum markers of hepatitis delta infection in intravenous drug abusers.
    Lake-Bakaar G; Bhat K; Govindarajan S
    J Lab Clin Med; 1994 Oct; 124(4):564-8. PubMed ID: 7930880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis delta virus infection in Taiwan.
    Liaw YF; Lin HH; Chu CM; Sheen IS; Huang MJ
    Prog Clin Biol Res; 1987; 234():479-83. PubMed ID: 3628418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High prevalence of delta virus infection in Thai intravenous drug abusers.
    Louisirirotchanakul S; Wasi C; Uneklabh C; Phutiprawan T; Suwanagool S; Chainuvati T; Thongcharoen P
    Southeast Asian J Trop Med Public Health; 1988 Jun; 19(2):191-5. PubMed ID: 3227398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prevalence of anti-delta antibodies in HBsAg carriers].
    Söyletir G; Babacan F; Göral M; Can A
    Mikrobiyol Bul; 1989 Apr; 23(2):97-101. PubMed ID: 2626106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delta hepatitis in Malaysia.
    Sinniah M; Dimitrakakis M; Tan DS
    Southeast Asian J Trop Med Public Health; 1986 Jun; 17(2):229-33. PubMed ID: 3787309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prevalence of antibody to delta virus in western Canada.
    Cheng HH; Wang DQ; Minuk GY; Anand CM; Stowe TC; Buchan KA
    Clin Invest Med; 1986; 9(3):156-9. PubMed ID: 3757321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The intrahepatic expression of the hepatitis B virus in chronic delta hepatitis].
    Ramalho F; Velosa J; Costa A; Baptista A; de Moura MC
    Acta Med Port; 1993 May; 6(5):187-91. PubMed ID: 8337951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-hepatitis delta virus seroprevalence and risk factors in patients with hepatitis B in Southeast Turkey.
    Celen MK; Ayaz C; Hosoglu S; Geyik MF; Ulug M
    Saudi Med J; 2006 May; 27(5):617-20. PubMed ID: 16680248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High prevalence of hepatitis B, C and delta virus infections among blood donors in Mongolia.
    Tsatsralt-Od B; Takahashi M; Nishizawa T; Inoue J; Ulaankhuu D; Okamoto H
    Arch Virol; 2005 Dec; 150(12):2513-28. PubMed ID: 16012782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prevalence of serological markers of viral hepatitis A, B and delta in apparently healthy schoolchildren of Huanta, Peru].
    Cabezas C; Gotuzzo E; Escamilla J; Phillips I
    Rev Gastroenterol Peru; 1994; 14(2):123-34. PubMed ID: 7948940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative analysis of disease activity in patients of chronic hepatitis B virus, with and without superinfection with hepatitis D virus; an experience at tertiary care centre.
    Das K; Ali H; Mahmood T; Munir SM; Ahmed T; Farooq MU
    J Ayub Med Coll Abbottabad; 2008; 20(2):39-42. PubMed ID: 19385455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular epidemiological and clinical aspects of hepatitis D virus in a unique triple hepatitis viruses (B, C, D) endemic community in Taiwan.
    Lu SN; Chen TM; Lee CM; Wang JH; Tung HD; Wu JC
    J Med Virol; 2003 May; 70(1):74-80. PubMed ID: 12629646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis B virus (HBV) and dual HBV-hepatitis delta virus (HDV) infection in apparently healthy persons.
    Brehar-Cioflec D; Claici C; Roşiu N; Negrea DA; Moldovan R; Coşniţă M
    Rom J Virol; 1998; 49(1-4):3-10. PubMed ID: 10892421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis delta virus infection: a recently imported disease in New Zealand.
    Ramirez AM; Lee SP; Woodfield DG
    N Z Med J; 1987 Apr; 100(822):235-7. PubMed ID: 3454892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seroepidemiology of hepatitis B, delta and human immunodeficiency virus infections in Hamadan province, Iran: a population based study.
    Amini S; Mahmoodi MF; Andalibi S; Solati AA
    J Trop Med Hyg; 1993 Oct; 96(5):277-87. PubMed ID: 8411302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infection with the delta agent in chronic HBsAg carriers.
    Smedile A; Dentico P; Zanetti A; Sagnelli E; Nordenfelt E; Actis GC; Rizzetto M
    Gastroenterology; 1981 Dec; 81(6):992-7. PubMed ID: 7286594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.